{
  "format": "listen-step-protocol@1",
  "kind": "module",
  "name": "生物治疗制品的 CD4⁺ T 细胞增殖免疫原性读数",
  "tags": [
    "免疫原性",
    "CGT"
  ],
  "authors": [
    "Robin E. Walsh",
    "Angela Nix",
    "Chloé Ackaert",
    "Aurélie Mazy",
    "Jana Schockaert",
    "Sofie Pattyn",
    "Laurent Malherbe"
  ],
  "source": {
    "title": "Preclinical immunogenicity risk assessment of biotherapeutics using CD4 T cell assays",
    "authors": [
      "Robin E. Walsh",
      "Angela Nix",
      "Chloé Ackaert",
      "Aurélie Mazy",
      "Jana Schockaert",
      "Sofie Pattyn",
      "Laurent Malherbe"
    ],
    "doi": "10.3389/fimmu.2024.1406040",
    "url": "https://doi.org/10.3389/fimmu.2024.1406040",
    "license": "CC BY 4.0",
    "licenseUrl": "https://creativecommons.org/licenses/by/4.0/",
    "adaptation": "从指定小节择取操作或判读步骤，改写为中文并重组为 Listen Step 模块。",
    "scope": "Methods 2.2–2.4",
    "year": 2024
  },
  "steps": [
    {
      "order": 1,
      "action": "整理同一供者的测试制品、培养基阴性和 KLH 阳性对照。明确使用去 CD8 的 PBMC 或自体 DC／CD4⁺ 共培养格式。"
    },
    {
      "order": 2,
      "action": "在流式数据中选择活的 CD3⁺CD4⁺ 细胞，用 CFSE 稀释判定增殖。"
    },
    {
      "order": 3,
      "action": "以同供者阴性对照计算细胞分裂指数，逐供者记录反应并汇总供者阳性频率。"
    },
    {
      "order": 4,
      "action": "分开报告不同 assay 格式。核对阳性对照与供者样本数，将结果用于体外免疫原性风险比较。"
    }
  ],
  "tables": [
    {
      "name": "原文署名与许可",
      "afterStep": 0,
      "header": [
        "字段",
        "内容"
      ],
      "rows": [
        [
          "原文",
          "Preclinical immunogenicity risk assessment of biotherapeutics using CD4 T cell assays"
        ],
        [
          "作者",
          "Robin E. Walsh；Angela Nix；Chloé Ackaert；Aurélie Mazy；Jana Schockaert；Sofie Pattyn；Laurent Malherbe"
        ],
        [
          "原文链接",
          "https://doi.org/10.3389/fimmu.2024.1406040"
        ],
        [
          "许可",
          "CC BY 4.0 https://creativecommons.org/licenses/by/4.0/"
        ],
        [
          "改编及范围",
          "从指定小节择取操作或判读步骤，改写为中文并重组为 Listen Step 模块。 来源小节：Methods 2.2–2.4"
        ]
      ]
    }
  ]
}
